"One of the things that people don't do enough, especially in Biotech, is try to think of the market problem. Rather than going from your bit of technology and trying to fit that into the market, to get explosive growth we need to flip that on its head and think about the market first."
Nirmesh Patel was one of the original founders of Cambridge Cancer Genomics and has recently transitioned into VC with The Venture Collective, while playing a key role in the Cancer Tech Accelerator.
Nirmesh joined us to talk about his journey so far, crossing over into VC, the importance of activation energy and his learns from startup success.
Podden och tillhörande omslagsbild på den här sidan tillhör Tom Froggatt. Innehållet i podden är skapat av Tom Froggatt och inte av, eller tillsammans med, Poddtoppen.
